Skip to content

Clinical trials

Completed Phase 3 Autistic Disorder trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autistic Disorder Phase: Phase 3 Status: Completed Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20042
20052
20063
20075
20091
20104
20124
20132
20151
20161
20181
20192
20201
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed38

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Otsuka Pharmaceutical Development & Commercialization, Inc.5
Indiana University4
The University of Hong Kong4
Curemark3
Massachusetts General Hospital2
Otsuka Pharmaceutical Co., Ltd.2
Sumitomo Pharma America, Inc.2
University of California, San Francisco2
Assaf-Harofeh Medical Center1
Assistance Publique - Hôpitaux de Paris1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autistic Disorder38
Autism Spectrum Disorder12
Child Development Disorders, Pervasive4
Asperger Syndrome3
Attention Deficit Disorder with Hyperactivity1
Bipolar Disorder1
Developmental Disabilities1
Marijuana Abuse1
Rett Syndrome1
Schizophrenia1

Trials

Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.